What Do Kidney Failure, Short Kids and the Vagus Nerve Have in Common?

Dermatology research and clinical applications take center stage as the hosts evaluate recent studies on pediatric growth, inflammatory skin conditions, and novel therapeutic interventions. Isotretinoin treatment shows no significant impact on final adult height despite temporary velocity dips, while Dupilumab appears to rescue linear growth in children with atopic dermatitis. Transcutaneous auricular vagus nerve stimulation emerges as a potential, cost-effective treatment for erythematotelangiectatic rosacea, and N-acetylcysteine shows promise as an adjunct for vitiligo. The discussion also highlights the efficacy of topical ruxolitinib for hidradenitis suppurativa and raises concerns regarding the potential nephrotoxicity of glyoxylic acid in keratin-based hair treatments. Furthermore, the hosts critically examine the limitations of statistical modeling in clinical trial attrition and question the real-world efficacy differences between originator and biosimilar adalimumab in treating hidradenitis suppurativa.